Argus Research analyst John Staszak downgrades McCormick & Co (NYSE:MKC) from Buy to Hold.
Unveiling 17 Analyst Insights On Merck & Co
Providing a diverse range of perspectives from bullish to bearish, 17 analysts have published ratings on Merck &…